Speaker:

So, Nora, if I could start with you, perhaps first of all, obviously,

Speaker:

you've given us a very clear rationale for capacity assessments.

Speaker:

We understand that they're important.

Speaker:

Is it only a neuropsychologist that can provide a capacity assessment or are

Speaker:

other clinicians able to do that as well?

Speaker:

Yeah, that's a good question. Other clinicians are able to do it and GPs are

Speaker:

able to do it if it is not complex.

Speaker:

So, if someone comes to you and they have an early stage dementia,

Speaker:

but you can talk to them about that specific decision and you feel they have

Speaker:

a good understanding of what the factors are involved,

Speaker:

if their reasoning is okay, if you feel like they can understand consequences, you can understand.

Speaker:

You can make that decision about capacity. But when it is complex,

Speaker:

when you're not sure about their level of cognitive impairment or their level

Speaker:

of insight, then I would recommend sending for a neuropsychology assessment.

Speaker:

And the same obviously with other health professionals and neurologists can

Speaker:

obviously make that decision too.

Speaker:

But I should say we get a lot of referrals for capacity assessments from neurologists?

Speaker:

Yeah, I mean, I think it's a little bit like my comment before about clinical

Speaker:

neurophysiology. If it's not clear on the history and examination,

Speaker:

you can zap some nerves and get a bit more information.

Speaker:

It's the same sort of thing with neuropsychology.

Speaker:

We don't have access to the detailed neuropsychology that Nora and her colleagues do.

Speaker:

And that obviously can help support why you're saying somebody does or does not have capacity.

Speaker:

I guess, just following on from that, there are some questions about,

Speaker:

you know, how do we access neuropsychology?

Speaker:

How much does it cost?

Speaker:

If somebody has had an assessment and capacity is preserved, how long does that last?

Speaker:

You know, do we have to do it again next month or next year?

Speaker:

You know, those sorts of kind of practical aspects.

Speaker:

A few questions there. In terms of,

Speaker:

they need to come back and have another assessment. So, your last question first.

Speaker:

It will only be, so if they're determined to have capacity.

Speaker:

So, we always assume someone has capacity to start with.

Speaker:

And so, if they're determined to have capacity after a formal assessment,

Speaker:

then we would assume they have capacity until there's some reason that makes

Speaker:

you think they maybe no longer have it.

Speaker:

So, if something questionable happens in their behaviour, if they start making

Speaker:

certain decisions that the family are very worried about then.

Speaker:

But it's not, we wouldn't say, okay, they have capacity now.

Speaker:

They need to come back in 12 months and we'll check it again.

Speaker:

We don't work like that. We work based on what their capacity is like going

Speaker:

forward and whether people become worried about it again.

Speaker:

One of your other questions was the cost.

Speaker:

And it is an expensive assessment. So, if you see a neuropsychologist privately for an assessment,

Speaker:

the assessment will vary, but generally a clinical assessment that includes

Speaker:

capacity is somewhere around $2,000.

Speaker:

It's a long assessment and very detailed, and that is sort of the general cost.

Speaker:

In fact, that's probably at the lower end. You'll find there's quite a range.

Speaker:

So cheap doesn't always mean value. I guess we'd make that point.

Speaker:

You know, Nora, obviously you worked for a long time in the public system.

Speaker:

Correct. Is clinical neuropsychology accessible in the public system?

Speaker:

We heard earlier from Sally about a speech pathology clinic run by students.

Speaker:

Is that an option in neuropsychology as well? Yeah. So, certainly at Royal Prince

Speaker:

Alfred Hospital and most public hospitals.

Speaker:

So I worked at RPA, but other public hospitals too, they won't accept capacity assessments.

Speaker:

If you're in area, you can be referred for a neuropsychology assessment and you can have it,

Speaker:

for free under Medicare, but they won't see a medico-legal one because these assessments,

Speaker:

you have to understand, so we have to do a level of testing that can then stand up in court.

Speaker:

So these assessments often end up being evidence where the will is contested or various things.

Speaker:

So the level of assessment has to be of a legal standard that holds up in court.

Speaker:

And the neuropsychologist working in the public system won't do them as part of those assessments.

Speaker:

I mean, waiting lists are also a massive problem, right? Waiting lists are very

Speaker:

long in the public system. That's true. And often you can't get in unless you're in area.

Speaker:

Now, student clinics are another thing, so universities have student clinics,

Speaker:

including Macquarie University,

Speaker:

where you can get a neuropsychology assessment for a discounted fee and the

Speaker:

student is under supervision with a qualified neuropsychologist.

Speaker:

But not all student clinics will do capacity assessments for that reason,

Speaker:

that they need to be of a level that will hold up in court and they just don't offer them.

Speaker:

So it depends on the student clinic.

Speaker:

Thanks, Nora. I'll let you have a little break. There's some more questions coming your way.

Speaker:

Candice, just thinking about headache. So I think, you know,

Speaker:

you presented some terrific cases of, you know, classic migraine that we all

Speaker:

are familiar with, I guess.

Speaker:

But what happens if you've got someone that has a history of classic migraine,

Speaker:

and then they develop some other type of headache?

Speaker:

You know, when do you get worried about their new symptoms?

Speaker:

I mean, in general, I get worried when they start developing a different type of headache.

Speaker:

Especially if it's not like the headache I mentioned, like the headache related

Speaker:

to overuse of antialgics.

Speaker:

So if there is anything new or different, someone who has migraine can,

Speaker:

like any other patient, have a different type of headache.

Speaker:

Like someone could develop giant cell arthritis, for instance,

Speaker:

on the background of migraine.

Speaker:

So I think when something is different, we always have to reassess our initial diagnosis.

Speaker:

I mean, the patient can have headache and can have a completely different neurological

Speaker:

condition, which needs further assessment.

Speaker:

And I mean, obviously that's clinical assessment, but brain imaging,

Speaker:

I mean, would you Would you do some form of brain imaging, CT or MRI at the

Speaker:

initial diagnosis, and then would you repeat that?

Speaker:

Yes, I would do a brain imaging, and I usually use brain MRIs if someone has

Speaker:

a different type of headache.

Speaker:

Whether I would repeat it...

Speaker:

It's a very good question. Probably not. I mean, as some of you might know,

Speaker:

we often see little things when we do brain MRIs, especially in patients with migraines.

Speaker:

Like we see some mild changes in the white matter, usually more anteriorly.

Speaker:

Whether we need to follow this up, I don't think, I don't do it at this stage.

Speaker:

I would repeat the MRI if I have a clinical reason to do it.

Speaker:

Yeah, I think just to comment on the white matter changes, that's often the

Speaker:

overlap between cognition and headache.

Speaker:

So somebody has an MRI, they've got a history of migraine, there's some white

Speaker:

matter changes, they'd start Googling and they say, oh my God,

Speaker:

I'm going to get dementia.

Speaker:

So that's a common reason for

Speaker:

us to see patients is the MRI kind of report showing white matter changes.

Speaker:

Just coming back to you, Nora, obviously the main bulk of your talk was about capacity and so on.

Speaker:

But I guess there are a few questions coming through about, you know,

Speaker:

how do we interpret neuropsychological testing in the context of,

Speaker:

say, adult onset ADHD, depression, anxiety?

Speaker:

You know, do we have a specific sort of pattern of deficits in these conditions

Speaker:

or, you know, are they more confounders, you know, when we're trying to assess patients?

Speaker:

There's very specific cognitive profiles that go with those different conditions,

Speaker:

so neuropsychology is very useful to diagnose those other conditions, yes.

Speaker:

So that's often a supportive investigation if we're not sure what's going on. Definitely.

Speaker:

And so obviously, I guess just to draw you out on that,

Speaker:

if somebody does have ADHD but you need to know if they've got capacity,

Speaker:

so you're kind of stacking two indications on top of each other,

Speaker:

you're able to interpret the capacity

Speaker:

in the context of their pre-existing condition. Correct. That's right.

Speaker:

Um, and, um, Candice, just coming back to you.

Speaker:

Um, so you mentioned a little bit about some of the more expensive treatments in chronic migraine.

Speaker:

And I think, uh, just to kind of, uh, repeat what you said, more than 15 headache

Speaker:

days per month, um, failing at least three conventional therapies.

Speaker:

Um, and for more than six months, I guess is the requirement for the PBS is that's right, isn't it?

Speaker:

So you know that how often

Speaker:

do you find that that patients actually meet those

Speaker:

criteria and I guess I'm just thinking about PBS and

Speaker:

how accessible these therapies are if patients don't meet the criteria that

Speaker:

we've outlined yeah I mean it's a very tricky question because because these

Speaker:

drugs are so effective that it would be very nice if we could give it to many

Speaker:

more patients but obviously they are very expensive.

Speaker:

I mean, we try to fit as well as we can with the PBS criteria before we prescribe them.

Speaker:

I mean, I sometimes find myself still prescribing it, for instance,

Speaker:

because someone is already on an antidepressant, so I can't really prescribe another one.

Speaker:

So, I might hit that box as saying one, but then I would still try two other

Speaker:

medications before I go ahead with one of the expensive medications.

Speaker:

Yeah. I find it particularly difficult if patients have bad migraine,

Speaker:

but maybe they're 12 headaches a month or 10 headaches a month,

Speaker:

which is still bad, but they don't quite meet the PBS criteria.

Speaker:

What about pregnancy and perimenstrual headache?

Speaker:

Any suggestions on how migraine should be managed in that context?

Speaker:

So perimenstrual headaches, usually we would, there are different alternatives, I guess, we could in,

Speaker:

We could use an estrogen patch because it's usually when the estrogen drops

Speaker:

that the migraines will happen. So that's one of the options.

Speaker:

Or suggest that the woman takes a pill without stopping would be a possibility.

Speaker:

And so that definitely helps some patients.

Speaker:

Or planning for her to take a big dose of anti-inflammatory on the days that she would usually have.

Speaker:

The headaches. So kind of prophylactically, we know these two days before I

Speaker:

have my periods, I'm going to have a migraine.

Speaker:

Okay, let's take 800 milligrams of ibuprofen on these two days.

Speaker:

Tricky if the menstrual cycle is not regular though, isn't it?

Speaker:

Yeah, it is sometimes tricky. That's right. And pregnancy?

Speaker:

Pregnancy is a very difficult one. I mean, usually migraines get better during

Speaker:

pregnancy, but obviously the amount of medications we can use is very limited, so it's tricky.

Speaker:

Sorry. A lot of young women with the question of fertility, and potentially

Speaker:

they want to fall pregnant but they're not called Shuwen,

Speaker:

they are very unlikely to take any of these prophylactic medications because

Speaker:

except for beta blockers, in my mind, and tricyclic antidepressants,

Speaker:

the rest of them are kind of indicated during pregnancy.

Speaker:

So that makes it very difficult to use any of those in young, fertile women.

Speaker:

Yes. I guess the mainstay of migraine prophylaxis is tricyclic antidepressants, so that's helpful.

Speaker:

And the second most common class that's used would be a beta blocker. So that's helpful.

Speaker:

I guess the one we worry about as neurologists, not so much in the migraine

Speaker:

space, more in the epilepsy space is epilim or sodium valproate.

Speaker:

That can be used as a migraine prophylaxis, but it causes weight gain and hair thinning.

Speaker:

So you're often not using it in a young woman anyway, but certainly wouldn't

Speaker:

want to use it if they're potentially going to get pregnant.

Speaker:

I guess the other thing just to, I'm not sure you mentioned,

Speaker:

but there are some nerve blocks that can be used either as a kind of a bit of

Speaker:

a once-off treatment in somebody with chronic,

Speaker:

headache or, you know, if other therapies are not available to you.

Speaker:

So greater occipital nerve blocks, for example, are pretty safe, pretty simple.

Speaker:

It's just a bit of local anesthetic and steroid given locally around the greater

Speaker:

occipital nerve, that can sometimes give people, you know, eight to 12 weeks

Speaker:

of relief without a lot of systemic side effects or interaction.

Speaker:

So that's worth considering when you're stuck.

Speaker:

But, you know, you're right, these are very difficult situations for us to deal with.

Speaker:

Yes, yes, so for, yeah, you could use Botox, that's right, actually.

Speaker:

You could use Botox during pregnancy.

Speaker:

That's one of the most attractive things about these injected therapies.

Speaker:

I mean, unlike the newer injected therapies, the locally available ones,

Speaker:

Botox really doesn't go very far.

Speaker:

It doesn't, it shouldn't, I should say, get absorbed into the bloodstream.

Speaker:

It's really a local therapy.

Speaker:

So that's helpful.

Speaker:

Oh, we've got one last question. Please go ahead. Thank you for your talk.

Speaker:

I want to ask about the migraines and very classical picture in my GP practice

Speaker:

when I see a young woman with a migraine, particularly oral migraine and premenstrual,

Speaker:

but she can't be on the pill because of the contradiction.

Speaker:

What's your take on it?

Speaker:

I think taking anti-inflammatory at the time of the headaches,

Speaker:

like a big dose of anti-inflammatory.

Speaker:

I mean, she would like to be on the contraceptive pill as well.

Speaker:

So you're asking about what contraceptive methods are available to her?

Speaker:

Right. So rather than migraine part, you're thinking, is there a contraceptive

Speaker:

therapy that we can use in migraine? Is that what you mean?

Speaker:

I mean, as a contradiction, like for a young woman who has got migraines with

Speaker:

aura, how do you assess this sort of clinical scenario?

Speaker:

I see a lot of young women coming with migraines and being on the pill,

Speaker:

but neurologists would say, oh, this is a migraine without aura.

Speaker:

She can have this pill. She can have this medication.

Speaker:

What would you come into? I guess I'm just trying to understand your question.

Speaker:

You're asking, should you be stopping the oral contraceptive pill in somebody

Speaker:

like that? Is that what you mean?

Speaker:

Yeah, because migraine with aura is unfair and deficient. Yeah,

Speaker:

so we've got migraine without aura.

Speaker:

Should we be stopping the contraceptive pill or can we continue? Is that the question?

Speaker:

Yeah, okay. So, I mean, the thing we worry about when we say in this discussion is risk of stroke.

Speaker:

And we know that it's higher in migraine with aura in women who also smoke.

Speaker:

And I forgot the third one now. Are overweight. Yeah.

Speaker:

So these three factors combined, obviously, is a big worry, but I wouldn't stop

Speaker:

the pill in someone who has migraine with no aura.

Speaker:

I guess we're talking about an increase in relative risk of stroke.

Speaker:

So the absolute risk of stroke in a reproductive age woman is relatively low,

Speaker:

but obviously this is increasing the risk over that.

Speaker:

So I think certainly education and counselling and, you know,

Speaker:

informed consent, all of those things are very important.

Speaker:

You know, sometimes a low dose, a presto and only pill, if that's an option

Speaker:

that, you know, you could think about that.

Speaker:

And other forms of contraceptive, you know, I mean, And I think part of the

Speaker:

discussion has to involve all of those things with the patient.

Speaker:

But often the patients will say, look, this is the pill that works best for

Speaker:

me. It's got the lowest side effects.

Speaker:

You know, I don't want to come off it. So that's okay too, so long as they understand

Speaker:

all of the kind of bits and pieces around it, I guess.

Speaker:

All right. So thank you very much. We'll thank our panelists once again. Fantastic session.